These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 11955844
1. Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade. Giannattasio C, Achilli F, Failla M, Capra A, Vincenzi A, Valagussa F, Mancia G. J Am Coll Cardiol; 2002 Apr 17; 39(8):1275-82. PubMed ID: 11955844 [Abstract] [Full Text] [Related]
2. Radial artery flow-mediated dilatation in heart failure patients: effects of pharmacological and nonpharmacological treatment. Giannattasio C, Achilli F, Grappiolo A, Failla M, Meles E, Gentile G, Calchera I, Capra A, Baglivo J, Vincenzi A, Sala L, Mancia G. Hypertension; 2001 Dec 01; 38(6):1451-5. PubMed ID: 11751734 [Abstract] [Full Text] [Related]
3. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure. Shinohara H, Fukuda N, Soeki T, Sakabe K, Onose Y, Tamura Y. Heart Vessels; 2002 Dec 01; 17(2):47-52. PubMed ID: 12541093 [Abstract] [Full Text] [Related]
4. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure. Jorde UP, Ennezat PV, Lisker J, Suryadevara V, Infeld J, Cukon S, Hammer A, Sonnenblick EH, Le Jemtel TH. Circulation; 2000 Feb 29; 101(8):844-6. PubMed ID: 10694521 [Abstract] [Full Text] [Related]
5. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects. Murdoch DR, McDonagh TA, Farmer R, Morton JJ, McMurray JJ, Dargie HJ. Am Heart J; 2001 May 29; 141(5):800-7. PubMed ID: 11320369 [Abstract] [Full Text] [Related]
7. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems. Spinale FG, de Gasparo M, Whitebread S, Hebbar L, Clair MJ, Melton DM, Krombach RS, Mukherjee R, Iannini JP, O SJ. Circulation; 1997 Oct 07; 96(7):2385-96. PubMed ID: 9337215 [Abstract] [Full Text] [Related]
8. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. Brunner-La Rocca HP, Vaddadi G, Esler MD. J Am Coll Cardiol; 1999 Apr 07; 33(5):1163-73. PubMed ID: 10193712 [Abstract] [Full Text] [Related]
10. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators. Lang RM, Elkayam U, Yellen LG, Krauss D, McKelvie RS, Vaughan DE, Ney DE, Makris L, Chang PI. J Am Coll Cardiol; 1997 Oct 07; 30(4):983-91. PubMed ID: 9316528 [Abstract] [Full Text] [Related]
16. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure. Shen YT, Wiedmann RT, Greenland BD, Lynch JJ, Grossman W. Cardiovasc Res; 1998 Aug 07; 39(2):413-22. PubMed ID: 9798526 [Abstract] [Full Text] [Related]
17. Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure. Joannides R, Bizet-Nafeh C, Costentin A, Iacob M, Derumeaux G, Cribier A, Thuillez C. Hypertension; 2001 Dec 01; 38(6):1446-50. PubMed ID: 11751733 [Abstract] [Full Text] [Related]
20. [Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)]. Tereshchenko SN, Kobalova ZhD, Demidova IV, Moiseev VS. Ter Arkh; 1997 Dec 01; 69(12):40-3. PubMed ID: 9503533 [Abstract] [Full Text] [Related] Page: [Next] [New Search]